Department of Medicine, University of Rome, Tor Vergata, Italy.
University of Rome, Tor Vergata, Italy.
Int J Immunopathol Pharmacol. 2014 Apr-Jun;27(2):287-9. doi: 10.1177/039463201402700217.
Ultraviolet B (UVB 290-320 nm) radiation has been used in the treatment of different skin diseases. Light sources with narrowband UVB output spectrum have been developed with the aim of increasing the rates of beneficial to side effect profile of the treatment. Narrowband UVB phototherapy using fluorescent lamps (TL01, 311∓2nm) has been widely adopted over the past 10 years. Monochromatic Excimer Light (MEL) represents a new source of narrow-band UVB emitting at 308 nm and guarantees a safe and effective approach to different chronic and recurrent skin diseases thanks to its potent and selective immunosuppressant action.
紫外线 B(UVB 290-320nm)辐射已被用于治疗不同的皮肤疾病。具有窄带 UVB 输出光谱的光源已被开发出来,目的是提高治疗的“有益副作用”比例。过去 10 年来,荧光灯(TL01,311-2nm)的窄带 UVB 光疗已被广泛采用。单色准分子光(MEL)是一种新的窄带 UVB 光源,其在 308nm 处发射,由于其强大而选择性的免疫抑制作用,为治疗不同的慢性和复发性皮肤病提供了一种安全有效的方法。